Main Session
Sep 28
SS 16 - Early Stage and Locally Advanced NSCLC

178 - A Dose Escalation Study of Papaverine As a Selective Hypoxic Radiosensitizer for Lung Stereotactic Body Radiation Therapy (SBRT) In the Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC) and Other Malignancies

10:55am - 11:05am ET

Presenter(s)

Jeremy Brownstein, MD, MS Headshot
Jeremy Brownstein, MD, MS - Ohio State University James Cancer Hospital, Columbus, OH